Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

Bibliographic Details
Main Authors: Redmond, William L, Linch, Stefanie N, Kasiewicz, Melissa J
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991178/
id pubmed-3991178
recordtype oai_dc
spelling pubmed-39911782014-05-05 Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity Redmond, William L Linch, Stefanie N Kasiewicz, Melissa J Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991178/ http://dx.doi.org/10.1186/2051-1426-1-S1-P87 Text en Copyright © 2013 Redmond et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Redmond, William L
Linch, Stefanie N
Kasiewicz, Melissa J
spellingShingle Redmond, William L
Linch, Stefanie N
Kasiewicz, Melissa J
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
author_facet Redmond, William L
Linch, Stefanie N
Kasiewicz, Melissa J
author_sort Redmond, William L
title Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
title_short Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
title_full Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
title_fullStr Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
title_full_unstemmed Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
title_sort combined targeting of co-stimulatory (ox40) and co-inhibitory (ctla-4) pathways elicits potent effector t cells capable of driving robust anti-tumor immunity
description
publisher BioMed Central
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991178/
_version_ 1612079626136322048

Similar Items